Clinical Trials Sponsored by Lombardi Cancer Research Center

Total 9744 results

H. Lee Moffitt Cancer Center and Research Institute
American Cancer Society, Inc.

Terminated

Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors

Pancreatic Tumors

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Terminated

Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Terminated

Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Patient Navigator Project

Breast Cancer | Colon Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer (CTC)

Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer (ETC)

Ovarian Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Withdrawn

Management of Metastatic Breast Cancer in Frail Patients

Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Completed

BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Fred Hutchinson Cancer Center
Fox Chase Cancer Center; City of Hope Medical Center; Stanford University; Cedars-Sinai... and other collaborators

Completed

A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women

Epithelial Ovarian Cancer

United States
Rachel Sanborn
AstraZeneca; Providence Cancer Center, Earle A. Chiles Research Institute

Active, not recruiting

Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer

Lung Cancer | Non-small Cell Carcinoma

United States
Jonsson Comprehensive Cancer Center
Tobacco Related Disease Research Program

Recruiting

Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups

Colorectal Carcinoma

United States
Technische Universität Dresden
German Cancer Research Center; KKS Dresden

Not yet recruiting

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula (XandTX)

Periampullary Cancer | Postoperative Pancreatic Fistula

Germany
Fred Hutchinson Cancer Center
Kenya Medical Research Institute; Jhpiego

Recruiting

Pharmacy-based PrEP Delivery in Kenya

Hiv

Kenya
H. Lee Moffitt Cancer Center and Research Institute
GlaxoSmithKline

Recruiting

Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma

Penile Carcinoma

United States
Cedars-Sinai Medical Center
California Breast Cancer Research Program

Recruiting

Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women

Health Knowledge, Attitudes, Practice | Breast Cancer Female | Health Disparities | Cancer Screening

United States
H. Lee Moffitt Cancer Center and Research Institute
BeiGene

Recruiting

First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer

Prostate Cancer | Stage IV Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Active, not recruiting

Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

Renal Cell Carcinoma Stage IV

United States
Vanderbilt-Ingram Cancer Center
Human Animal Bond Research Institute

Completed

Animal-Assisted Interactions in Children With Life-Threatening Conditions and Their Parents

Advanced Cancer | Relapsed Cancer | Refractory Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca

Terminated

Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer

Breast Cancer | Hormone Receptor Positive Tumor

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Completed

TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer

Breast Cancer | Breast Cancer - Female | Breast Cancer - Male

United States
University of Hawaii
University of Hawaii Cancer Research Center

Terminated

Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Completed

Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention

Graft Versus Host Disease | GVHD

United States
H. Lee Moffitt Cancer Center and Research Institute
Bayer

Completed

Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

Prostate Cancer | Prostate Adenocarcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene

Completed

Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Completed

Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)

Graft-Versus-Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene

Completed

Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide

Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Terminated

Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)

Liver Cancer

United States
University of Hawaii
University of Hawaii Cancer Research Center

Completed

Goal Setting and Lifestyle (GSDB)

Physical Activity | Diet

United States
German Cancer Research Center
Mukoviszidose Institut gGmbH; Heidelberg University

Completed

Magnetic Resonance Imaging (MRI) for Early Diagnosis of Cystic Fibrosis (CF)

Cystic Fibrosis | Lung Disease

Germany
Heidelberg University
University of Heidelberg Medical Center; German Cancer Research Center; National... and other collaborators

Completed

Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease

Breast Cancer | Colorectal Cancer | Prostate Cancer | Physicians | Nurses
Ralph Hauke
Prometheus Laboratories; Nebraska Cancer Specialists; Midwest Cancer Center-Legacy

Terminated

Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma

Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Dendreon

Recruiting

Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer

Prostate Cancer | Metastatic Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Servier

Recruiting

CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

Acute Lymphoblastic Leukemia

United States
National Cancer Center, Japan
H.U. Group Research Institute G.K.

Recruiting

Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study

HER2-positive Breast Cancer

Japan
H. Lee Moffitt Cancer Center and Research Institute
ImmunoRestoration

Recruiting

Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab

HER2-positive Breast Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Recruiting

Axitinib + Ipilimumab in Advanced Melanoma

Melanoma

United States
Jonsson Comprehensive Cancer Center
Pfizer; Translational Research in Oncology

Recruiting

Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer

Recurrent Extensive Stage Small Cell Lung Carcinoma | Refractory Extensive Stage Small Cell Lung Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Pfizer

Active, not recruiting

Avelumab With Radiotherapy in Patients With Leptomeningeal Disease

Leptomeningeal Metastases | Leptomeningeal Disease

United States
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca

Active, not recruiting

Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer

Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Completed

Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma

Melanoma | Skin Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
GlaxoSmithKline

Terminated

Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia

Thrombocytopenia | Myelodysplastic Syndrome (MDS)

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Completed

BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
Jonsson Comprehensive Cancer Center
Novartis; Translational Research in Oncology

Completed

Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene

Completed

Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)

Leukemia

United States
M.D. Anderson Cancer Center
CLL Global Research Foundation Alliance

Withdrawn

Autologous ROR1R-CAR-T Cells for Chronic Lymphocytic Leukemia (CLL)

Leukemia
H. Lee Moffitt Cancer Center and Research Institute
AstraZeneca

Completed

Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Completed

Phase I Trial of Combination of FOLFIRI and SOM 230

Gastrointestinal Tumor

United States
H. Lee Moffitt Cancer Center and Research Institute
Sanofi

Terminated

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Completed

CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)

Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis

Terminated

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

Multiple Myeloma

United States, Puerto Rico

Clinical Trials Sponsored by Lombardi Cancer Research Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations